Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 10:12:25 GMT 2023
by
admin
on
Sat Dec 16 10:12:25 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
P256HB60FF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
500315
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/16/1667
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DE-143
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY | |||
|
1613313-09-9
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY | |||
|
Rovalpituzumab tesirine
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY | |||
|
DB13017
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY | |||
|
10141
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY | |||
|
SUB181948
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY | |||
|
C107678
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY | |||
|
P256HB60FF
Created by
admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_145 | 1_201 |
| 1_262 | 1_322 |
| 1_368 | 1_426 |
| 2_22 | 2_96 |
| 2_145 | 2_201 |
| 2_262 | 2_322 |
| 2_368 | 2_426 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| 1_221 | 3_214 |
| 2_221 | 4_214 |
| 1_227 | 2_227 |
| 1_230 | 2_230 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_298 |
| N | 2_298 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->CONJUGATED TOXIN |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|